The exclusion of other chronic liver diseases including “excess” alcohol intake has until now
been necessary to establish a diagnosis of metabolic dysfunction-associated fatty liver …

Fatty liver associated with metabolic dysfunction is common, affects a quarter of the
population, and has no approved drug therapy. Although pharmacotherapies are in …

Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype
nonalcoholic steatohepatitis (NASH) are becoming the leading cause of liver-related …

OBJECTIVES: It is known that liver disease can cause an imbalance in the coagulation
system, but available data on liver disease and risk of venous thromboembolism are …

Several prospective studies have shown a moderate positive association between
increasing circulating insulin‐like growth factor‐I (IGF‐I) levels and colorectal cancer risk …

Background Direct‐acting oral anticoagulants (DOAC s) are used in patients with splanchnic
vein thrombosis (SVT) and cirrhosis, but evidence for safety and efficacy in this setting is …

Western style diets and lifestyles are associated with increasing rates of obesity, diabetes
and insulin resistance. Higher circulating insulin levels may modulate cell proliferation and …

Macrophages are involved in inflammation and liver fibrosis and soluble (s) CD163 is a
specific marker of activated macrophages. We investigated associations between sCD163 …

Objective: The aim of this study was to examine the relationship of diet with serum insulin-
like growth factor-I (IGF-I) and IGF-binding protein-3 in women. Design: Cross-sectional …

Background and Aims Electronic health record (EHR)‐based research allows the capture of
large amounts of data, which is necessary in NAFLD, where the risk of clinical liver …